Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Burning Rock Biotech Ltd ADR (BNR)

Burning Rock Biotech Ltd ADR (BNR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 35,687
  • Shares Outstanding, K 10,244
  • Annual Sales, $ 75,700 K
  • Annual Income, $ -92,070 K
  • 60-Month Beta 0.15
  • Price/Sales 0.45
  • Price/Cash Flow N/A
  • Price/Book 0.39
Trade BNR with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.31 +3.32%
on 09/18/24
6.77 -49.45%
on 08/20/24
-2.69 (-44.03%)
since 08/19/24
3-Month
3.31 +3.32%
on 09/18/24
7.57 -54.79%
on 07/15/24
-3.71 (-52.03%)
since 06/18/24
52-Week
3.31 +3.32%
on 09/18/24
11.70 -70.77%
on 10/18/23
-5.68 (-62.42%)
since 09/19/23

Most Recent Stories

More News
Engine Capital Sends Letter to Brenntag’s Supervisory Board of Directors Regarding the Need for a Timely Spin-off of the Specialties Business

Engine Capital LP, which owns approximately 1% of Brenntag SE’s (XETRA: BNR) (“Brenntag” or the “Company”) outstanding shares, today announced that it has sent the below letter to members of...

BNR : 3.42 (-1.83%)
Burning Rock Biotech Limited (BNR) Q2 2022 Earnings Call Transcript

BNR earnings call for the period ending June 30, 2022.

BNR : 3.42 (-1.83%)
Why Shares of Alibaba, JD.com, and Burning Rock Biotech Are Rising Today

Chinese stocks continue to benefit from a preliminary agreement between the U.S. and China on a long-standing auditing dispute.

BABA : 88.25 (+4.54%)
JD : 28.62 (+6.32%)
BNR : 3.42 (-1.83%)
Burning Rock Provides Second Quarter 2022 Business Updates and Schedules Earnings Release on August 31, 2022

GUANGZHOU, China, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the...

BNR : 3.42 (-1.83%)
Burning Rock Announces 2022 Annual General Meeting to be Held on September 8, 2022

GUANGZHOU, China, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on...

BNR : 3.42 (-1.83%)
Burning Rock Announces Resignation of Director

GUANGZHOU, China, July 14, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the...

BNR : 3.42 (-1.83%)
Burning Rock Announces the Launch of China’s First Prospective Interventional Validation Study on Multi-Cancer Early Detection - the PREVENT Study

CHENGDU, China, June 30, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the...

BNR : 3.42 (-1.83%)
Burning Rock Announces Changes to Board Composition

GUANGZHOU, China, June 24, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the...

BNR : 3.42 (-1.83%)
Burning Rock Announces US$10 Million Share Repurchase Program

GUANGZHOU, China, June 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the...

BNR : 3.42 (-1.83%)
Burning Rock Announces Plan to Pursue An Alternative Listing

GUANGZHOU, China, June 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the...

BNR : 3.42 (-1.83%)

Business Summary

Burning Rock Biotech Limited focuses on the application of next generation sequencing technology in the field of precision oncology. Its business consists of NGS-based therapy selection testing for late-stage cancer patients as well as NGS-based cancer early detection. Burning Rock Biotech Limited is...

See More

Key Turning Points

3rd Resistance Point 3.74
2nd Resistance Point 3.62
1st Resistance Point 3.55
Last Price 3.42
1st Support Level 3.36
2nd Support Level 3.24
3rd Support Level 3.17

See More

52-Week High 11.70
Fibonacci 61.8% 8.50
Fibonacci 50% 7.51
Fibonacci 38.2% 6.51
Last Price 3.42
52-Week Low 3.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar